Home
Clinical Trials
Omepral® Tablets Special Cli...

Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis

Last Updated: 2009-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10703 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-06-30

Study Completion Date

2008-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This open label, non-interventional study is to compare the efficacy of Omepral® tablet and any other treatments excepting proton pump inhibitors (PPIs) for the treatment of various type of acid reflux related symptoms in patients with reflux esophagitis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Reflux Esophagitis Phase III Study (Initial Treatment)

NCT00633932

Reflux Esophagitis

COMPLETED PHASE3

Reflux Esophagitis Phase III Study (Maintenance Treatment)

NCT00634114

Reflux Esophagitis

COMPLETED PHASE3

Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

NCT00259077

Non-erosive Reflux Disease

COMPLETED PHASE3

A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)

NCT00626535

Symptomatic Gastroesophageal Reflux Disease (sGERD)

COMPLETED PHASE3

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

NCT01397084

Gastroesophageal Reflux Disease GERD Reflux Esophagitis

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Reflux Esophagitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients newly diagnosed as erosive esophagitis or history of erosive esophagitis confirmed by endoscopy.
* Patients who answered questionnaires of quality of life (QOLRAD-J), symptom severity and frequency and treatment satisfaction.
* During the past 1 week , patients who have either two days or more with heartburn or acid taste in the mouth of any severity

Exclusion Criteria

* Patients receiving treatment with proton pump inhibitors, which make stomach acid decreased during the last 4 weeks prior to enrolment.
* Patients who cannot answer questionnaires of quality of life (QOLRAD-J), symptom severity and frequency and treatment satisfaction.
* Patients included previously in this study.

Eligible Sex

ALL

Accepts Healthy Volunteers